Bleeding clinical trials in Iowa
4 studies for Bleeding are looking for participants at sites in Iowa.
Cities in Iowa
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- The University of Iowa, Iowa City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- The University of Iowa, Iowa City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06948318Onyx™ Liquid Embolic IDE Clinical Study
- University of Iowa Hospitals and Clinics, Iowa City
Recruiting
Ages 22 and older · All sexes · Updated Oct 13, 2026 · NCT06742801Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- Stead Family Children's Hospital, Iowa City
RecruitingPhase 2/3
Up to age 17 · All sexes · Updated Jun 8, 2026 · NCT04924322From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.